How are we at a point where women are terrified of a hormone they've had in their bodies most of their lives?

Many of us have heard horrible things about estrogen and its connection to breast cancer. A lot of this public aversion stems from a study that came out in the early 2000s called the Women's Health Initiative (WHI).

The WHI was a landmark study designed to define the risks and benefits of interventions, notably hormonal therapy. Unfortunately, when journals and the media reported on the findings, they didn’t put them into the appropriate clinical context and did not mention the study’s limitations. Ultimately, this led to women ditching their hormones en masse, suffering in silence without an alternative.

Today I’m sharing what you need to know about the WHI, what the data shows about the connection between hormone therapy and the risk of disease, why we need to shift our perspective on hormone therapy, and alternatives for women who can’t benefit from estrogen therapy.

Let’s try not to be afraid of estrogen - it’s not a bad thing.

Episode Highlights

• Telling women across the board not to go on hormones is a misogynistic statement
• What you need to know about the Women’s Health Initiative study
• The problem with how the media reported the results of the WHI study
• Positive outcomes of hormone therapy identified in the study
• Limitations of the WHI
• Considerations for women with a history of breast cancer
• What the studies showed about the benefits for osteoporosis prevention
• The relationship between estrogen therapy and increased risk of dementia and stroke
• Detoxifying estrogen in your body
• My confession for estrogen replacement
• Alternatives to estradiol for menopause symptoms

Resources

Dr. Tassone's Practice | Tassone Advanced Gynecology

Dr. Tassone's Book | The Hormone Balance Bible

Hormone Archetype Quiz | Hormonal Mapping System

Medical Disclaimer
This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.

In this episode Dr. Shawn Tassone discusses the use of metformin, berberine, and dihydroberberine for weight loss in women, particularly those in perimenopause and menopause.

He explains that while GLP-1 medications like Ozempic and Monjaro are effective for weight loss, some women may prefer to try metformin, berberine, or dihydroberberine due to concerns or fear of injectable medications. He provides an overview of each medication, including their uses, dosages, side effects, and cost. Dr. Tassone also discusses the differences between berberine and dihydroberberine, and why he prefers dihydroberberine for weight loss.

He also emphasizes the importance of consulting with a doctor and monitoring labs while using these medications.

Episode Highlights

• Why Metformin, berberine, and dihydroberberine are medications/supplements that can be used for weight loss
• Why some women may prefer to try metformin, berberine, or dihydroberberine
• How Metformin can be beneficial for women with polycystic ovarian syndrome.
• Benefits of Berberine
• The difference between Berberine and Dihydroberberine
• The importance of consulting with a doctor, monitoring labs, and cycling off these medications/supplements periodically.
• Cost difference between Metformin, berberine and dihydroberberine
• How personal preference plays a role in choosing between metformin, berberine, and dihydroberberine for weight loss
• Why you should avoid supplements advertised as similar to GLP-1 medications

Resources

Dr. Shawn Tassone's Practice | Tassone Advanced Gynecology

Dr. Shawn Tassone's Book | Hormone Balance Bible

Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormonal Archetype Quiz

Medical Disclaimer

This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.

In this episode, Dr. Shawn Tassone discusses the recent recommendations from the United States Preventive Services Task Force (USPSTF) regarding mammography guidelines. The USPSTF recommends biennial screening mammography for women aged 40 to 74, with a B recommendation. Dr. Tassone explains the incidence and mortality rates of breast cancer, particularly among non-Hispanic white and non-Hispanic black women.

He also addresses the potential harms of mammography, such as false positive results and overdiagnosis. Dr. Tassone discusses thermography as an alternative to mammography and emphasizes the importance of individualized screening based on risk factors.

Episode Highlights

• The USPSTF recommends biennial screening mammography for women aged 40 to 74, with a B recommendation.
• Breast cancer is the second most common cancer and cause of death among women in the US.
• Mammography has potential harms, including false positive results and overdiagnosis.
• Thermography is not currently considered an alternative to mammography.
• Screening should be individualized based on risk factors.

Resources

Dr. Shawn Tassone's Practice | Tassone Advanced Gynecology

Dr. Shawn Tassone's Book | The Hormone Balance Bible

Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormone Archetype Quiz

Medical Disclaimer

This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your healthcare professional for any medical questions.